pharm exam 3

pharm exam 3
42問 • 2023-12-04
  • Julia Skellie
  • 通報

    Antagonist

    Antagonist

    Julia Skellie · 178問 · 2年前

    Antagonist

    Antagonist

    178問 • 2年前
    Julia Skellie

    Monitors

    Monitors

    Julia Skellie · 144問 · 2年前

    Monitors

    Monitors

    144問 • 2年前
    Julia Skellie

    Positioning

    Positioning

    Julia Skellie · 88問 · 2年前

    Positioning

    Positioning

    88問 • 2年前
    Julia Skellie

    arterial vasodilators, peripheral vasodilators, CCB

    arterial vasodilators, peripheral vasodilators, CCB

    Julia Skellie · 122問 · 2年前

    arterial vasodilators, peripheral vasodilators, CCB

    arterial vasodilators, peripheral vasodilators, CCB

    122問 • 2年前
    Julia Skellie

    AntiArrhythmics

    AntiArrhythmics

    Julia Skellie · 70問 · 2年前

    AntiArrhythmics

    AntiArrhythmics

    70問 • 2年前
    Julia Skellie

    just dont forget:

    just dont forget:

    Julia Skellie · 8問 · 2年前

    just dont forget:

    just dont forget:

    8問 • 2年前
    Julia Skellie

    Rspiratory

    Rspiratory

    Julia Skellie · 42問 · 2年前

    Rspiratory

    Rspiratory

    42問 • 2年前
    Julia Skellie

    Monitored and Conscious Sedation

    Monitored and Conscious Sedation

    Julia Skellie · 48問 · 2年前

    Monitored and Conscious Sedation

    Monitored and Conscious Sedation

    48問 • 2年前
    Julia Skellie

    Emergence

    Emergence

    Julia Skellie · 29問 · 2年前

    Emergence

    Emergence

    29問 • 2年前
    Julia Skellie

    PACU

    PACU

    Julia Skellie · 14問 · 2年前

    PACU

    PACU

    14問 • 2年前
    Julia Skellie

    Random

    Random

    Julia Skellie · 19問 · 2年前

    Random

    Random

    19問 • 2年前
    Julia Skellie

    Pharm Induction Agents

    Pharm Induction Agents

    Julia Skellie · 58問 · 2年前

    Pharm Induction Agents

    Pharm Induction Agents

    58問 • 2年前
    Julia Skellie

    Laparoscopic Surgery

    Laparoscopic Surgery

    Julia Skellie · 39問 · 2年前

    Laparoscopic Surgery

    Laparoscopic Surgery

    39問 • 2年前
    Julia Skellie

    Hematology Coagulation

    Hematology Coagulation

    Julia Skellie · 66問 · 2年前

    Hematology Coagulation

    Hematology Coagulation

    66問 • 2年前
    Julia Skellie

    LIVER

    LIVER

    Julia Skellie · 84問 · 2年前

    LIVER

    LIVER

    84問 • 2年前
    Julia Skellie

    ENT

    ENT

    Julia Skellie · 17問 · 2年前

    ENT

    ENT

    17問 • 2年前
    Julia Skellie

    Opioids

    Opioids

    Julia Skellie · 18問 · 2年前

    Opioids

    Opioids

    18問 • 2年前
    Julia Skellie

    MH

    MH

    Julia Skellie · 32問 · 2年前

    MH

    MH

    32問 • 2年前
    Julia Skellie

    NeuroSurg

    NeuroSurg

    Julia Skellie · 20問 · 2年前

    NeuroSurg

    NeuroSurg

    20問 • 2年前
    Julia Skellie

    Burns

    Burns

    Julia Skellie · 89問 · 2年前

    Burns

    Burns

    89問 • 2年前
    Julia Skellie

    Regional

    Regional

    Julia Skellie · 11問 · 2年前

    Regional

    Regional

    11問 • 2年前
    Julia Skellie

    問題一覧

  • 1

    what avoids opioid exposure?

    non-opioid analgesic techniques lack respiratory depression, physical dependence and abuse not regulated under controlled substances act multimodal adjuvants: NSAID magnesium lidocaine lyrica

  • 2

    NSAIDS are weak:

    acids

  • 3

    NSAIDS: low or high volume of distribution:

    low with minimal tissue binding

  • 4

    metabolizes NSAIDS:

    liver

  • 5

    NSAIDS and hepatic or renal disease:

    alter binding and metabolism more unbound drug more side effects

  • 6

    reduced renal function and NSAIDS:

    prolongs half life lower dose

  • 7

    irreversible binding NSAID

    aspirin

  • 8

    COX2 selective:

    celecoxib

  • 9

    NSAID recommended for cardiovascular disease:

    naproxen

  • 10

    COX2 major concerns:

    cardiovascular risks: MI HTN stroke HF

  • 11

    COX 1 inhibition causes: 1 2 3

    1. inhibit platelet aggregation 2. decrease renal blood flow 3. loss of gastric mucosa secretion - GI bleed, peptic ulcers

  • 12

    COX2 inhibition causes: 1 2 3

    1. anti inflammatory 2. antipyretic 2. analgesic

  • 13

    Ketorolac dose:

    30mg

  • 14

    Cox 2 have less _______ toxicity than non selective NSAID

    GI

  • 15

    which NSAID may be safter in perioperative setting:

    COX 2- celecoxib

  • 16

    major 4 adverse effects of NSAIDS

    1. cardiovascular risk- htn, hf, mi (more likely with cox 2) 2. respiratory- bronchospaspm, nasal polyps, dysnpnea, asthma 3. GI- peptic ulcer 4. hematologic- inhibits platelet aggregation- bleeding risk

  • 17

    symptoms of hypothyroidism

    fatigue weight gain myxedema depression

  • 18

    hyperthyroidism symptoms - Graves’ disease:

    muscle wasting weight loss hot exopathlamos

  • 19

    hypothyroidism treatment

    levothyroxine

  • 20

    levothyroxine vs liothyronine

    liothyronine has multiple dosing intervals, more potent, requires frequent lab work levothyroxine- once a day

  • 21

    levothyroxine MOA:

    T4 is converted to T3 intracellulary

  • 22

    when to take Levothyroxine

    empty stomach gel form available if intolerant

  • 23

    half life and steady state of levothyroxine

    7 day half life 4-6 weeks to steady state

  • 24

    4 categories to treat hyperthyroid

    1. antithryoid: interfere with synthesis of TH 2. ionic inhibitors: block iodide transport mechanism 3. high concentration iodine: decrease release of TH from gland and decrease synthesis 4. radioactive iodine: ionizing radiation to damage gland

  • 25

    adjuvant therapy for thryotoxicosis

    beta blockers CCB

  • 26

    hyperthyroidism: radioiodine medications: 1 2 3

    carbimazole methimazole porpylthiouracil PTU

  • 27

    beta blockers for hyperthyroidism

    propranolol nadolol

  • 28

    antithryoid drugs that categorized:

    thiourylenes

  • 29

    thiourylene prototype

    propylthioruracil

  • 30

    MOA of propylthioruracil

    bind and inhibit peroxidase enzyme preventing iodine organification (iodine reaction with tyrosyl residue of thyroglobulin) inhibiting formation of thyroid horomones

  • 31

    propylthioruracil vs methimazole

    propylthioruracil inhibits peripheral deiodination of T4 to T3 and methimazole does not

  • 32

    2 adverse effects of antithryoid drugs: propylthioruracil and methimazole:

    1. agranulocytosis 2. liver function

  • 33

    iodide MOA:

    quantity of bound iodine increases iodide has the capacity to limit its own transport: negative feedback inhibits release of TH- rapid and effective in severe thyrotoxicosis thyroid gland becomes less vascular, cells become smaller and firmer reaccumulates in the follicles

  • 34

    radioactive iodine MOA

    rapidly and efficiently trapped by thyroid and deposited into the colloid of the follicles beta particles are emitted that destroy parenchymal cells of the thyroid

  • 35

    treat thyroid storm:

    propylthioruracil radioactive dyes BB or CCB for tachydysththmias dexamethasone 10mg supportive measures: cooling or sedation

  • 36

    radiographic contrast: iopanoic acid and sodium ipodate MOA

    block thyroid hormone release as a result of the iodide released from the dyes inhibit T4 to T3 conversion

  • 37

    dexamethasone MOA for thyroid storm:

    inhibit conversion of T4 to T3

  • 38

    adverse effects of corticosteroids

    suppression of the hypothalamic pituitary adrenal axis weight gain skeletal muscle wasting

  • 39

    corticosteroids produce:

    anti-inflammatory effects

  • 40

    corticosteroid with more anti-inflammatory potency:

    dexamethasone least: cortisol

  • 41

    corticosteroids MAO

    cortisol attached to cytoplasmic receptors to enhance or suppress changes in the transcription of DNA and protein synthesis 2 receptors: mineralocorticoid: sodium and water retention: aldosterone -distal renal tubules, colon, salivary glands, hippocampus glucocorticoid: cortisol -widely distributed

  • 42

    clinical uses of corticosteroids

    allergy asthma antiemetic replacement therapy for deficient state: Addison anti-inflammatory acute adrenal insufficiency analgesia cerebral edema aspiration pneumonitis (laryngospasm) immunosuppression post intubation laryngeal edema- to de-swell or prevent myasthenia gravis arthritis